Document Detail

Back from irreversibility: use of percutaneous cardiopulmonary bypass for treatment of shock from refractory anaphylaxis during coronary intervention.
MedLine Citation:
PMID:  19494419     Owner:  NLM     Status:  MEDLINE    
Anaphylaxis during diagnostic catheterization and coronary intervention is a rare and potentially life-threatening complication. Fortunately, with standard intervention, fatality is rare. We report a case of medically refractory anaphylaxis during a coronary intervention that ultimately responded to percutaneous cardiopulmonary bypass (CPB). The proposed mechanics and use of CPB for shock are discussed.
Thomas Chengot; John Goncalves; Kevin Marzo
Related Documents :
937139 - Urinary excretion of kallikrein following myocardial infarction.
19468019 - Intractable cardiogenic shock in stress cardiomyopathy with left ventricular outflow tr...
3421879 - A case of cardiovascular collapse due to adrenal insufficiency.
16327039 - Four days of percutaneous cardiopulmonary support and sixteen days of percutaneous left...
16878049 - Meningococcal purpura fulminans treated with medicinal leeches.
10985709 - Implications of the timing of onset of cardiogenic shock after acute myocardial infarct...
16619119 - Insular infarcts and electrocardiographic changes at admission: results of the prognost...
16423369 - Cardioprotective effect of des-aspartate-angiotensin-i (daa-i) on cytokine gene express...
7630159 - Profibrillatory effects of lidocaine in the acutely ischemic porcine heart.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Journal of invasive cardiology     Volume:  21     ISSN:  1557-2501     ISO Abbreviation:  J Invasive Cardiol     Publication Date:  2009 Jun 
Date Detail:
Created Date:  2009-06-04     Completed Date:  2009-09-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8917477     Medline TA:  J Invasive Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e97-100     Citation Subset:  IM    
Cardiology Department, Winthrop-University Hospital, Mineola, NY 11501, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Coronary Syndrome / diagnosis,  therapy
Adrenergic Agonists / therapeutic use
Anaphylaxis / etiology*,  surgery*
Angioplasty, Transluminal, Percutaneous Coronary / adverse effects*
Cardiopulmonary Bypass*
Contrast Media / adverse effects*
Epinephrine / therapeutic use
Hypotension / chemically induced,  drug therapy
Treatment Outcome
Reg. No./Substance:
0/Adrenergic Agonists; 0/Contrast Media; 51-43-4/Epinephrine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Antegrade Balloon Transit of Retrograde Wire to Bail Out Dissected Left Main during Retrograde Chron...
Next Document:  One-step DNA Fragment Assembly and Circularization for Gene Cloning.